| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Jun Sun | Q48975693 |
| P2093 | author name string | Mei Shang | |
| P2860 | cites work | Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the attenuation of tumorigenesis in Apc(Min/+) mice | Q47447621 |
| LOWER LEVELS OF VITAMIN D CORRELATE WITH CLINICAL DISEASE ACTIVITY AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE. | Q47836802 | ||
| Vitamin D Deficiency Associated with Disease Activity in Patients with Inflammatory Bowel Diseases | Q48037160 | ||
| Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life | Q48683216 | ||
| Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. | Q50101913 | ||
| Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis | Q50454240 | ||
| Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis | Q50494526 | ||
| High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease. | Q53231256 | ||
| Adherence and anticarcinogenic effects of Bacillus polyfermenticus SCD in the large intestine. | Q53336611 | ||
| Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants. | Q53613669 | ||
| Lactobacillus acidophilus modulates inflammatory activity by regulating the TLR4 and NF-κB expression in porcine peripheral blood mononuclear cells after lipopolysaccharide challenge. | Q54252990 | ||
| Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. | Q54416920 | ||
| Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells. | Q54467599 | ||
| Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. | Q54551350 | ||
| VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis | Q59120549 | ||
| Bifidobacterium infantis35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells | Q59879275 | ||
| Calcium, dairy foods, vitamin D, and colorectal cancer risk: the Fukuoka Colorectal Cancer Study | Q82242220 | ||
| Molecular Genetics of Colorectal Cancer | Q82521439 | ||
| Lactobacilli facilitate maintenance of intestinal membrane integrity during Shigella dysenteriae 1 infection in rats | Q82740106 | ||
| The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis | Q84290217 | ||
| Effect of live Lactobacillus plantarum L2 on TNF-alpha-induced MCP-1 production in Caco-2 cells | Q84472596 | ||
| Ocotillol, a Majonoside R2 Metabolite, Ameliorates 2,4,6-Trinitrobenzenesulfonic Acid-Induced Colitis in Mice by Restoring the Balance of Th17/Treg Cells | Q85634872 | ||
| Lactobacillus plantarum NCU116 Attenuates Cyclophosphamide-Induced Immunosuppression and Regulates Th17/Treg Cell Immune Responses in Mice | Q87179481 | ||
| Critical roles of intestinal epithelial vitamin D receptor signaling in controlling gut mucosal inflammation | Q26995831 | ||
| Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease | Q27014906 | ||
| Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation | Q27327276 | ||
| Vitamin D and inflammatory bowel disease | Q28085484 | ||
| Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer | Q28210081 | ||
| Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3 | Q28258765 | ||
| Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study | Q28749202 | ||
| Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity | Q33309955 | ||
| Effect of the administration of a fermented milk containing Lactobacillus casei DN-114001 on intestinal microbiota and gut associated immune cells of nursing mice and after weaning until immune maturity | Q33343715 | ||
| Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells | Q33554139 | ||
| Bifidobacterium breve attenuates murine dextran sodium sulfate-induced colitis and increases regulatory T cell responses | Q33559718 | ||
| Lactobacillus plantarum inhibits intestinal epithelial barrier dysfunction induced by unconjugated bilirubin | Q33562329 | ||
| A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients | Q33590786 | ||
| Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4) | Q33711961 | ||
| Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation | Q33767034 | ||
| Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. | Q33960898 | ||
| Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats | Q34158029 | ||
| Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women | Q34162805 | ||
| Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis | Q34170678 | ||
| Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice | Q34286493 | ||
| Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development | Q34355992 | ||
| Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function | Q34374501 | ||
| VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation | Q34428997 | ||
| Suppressive effects of oral administration of heat-killed Lactobacillus acidophilus on T helper-17 immune responses in a bovine β-lactoglobulin-sensitized mice model | Q34499012 | ||
| Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases | Q34499153 | ||
| Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer? | Q34565686 | ||
| Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function | Q34587671 | ||
| A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease | Q34588311 | ||
| Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation | Q34629145 | ||
| Probiotics as modulators of the gut flora | Q34820531 | ||
| Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis | Q35032869 | ||
| Probiotics, nuclear receptor signaling, and anti-inflammatory pathways | Q35131051 | ||
| Vitamin D receptor activation protects against myocardial reperfusion injury through inhibition of apoptosis and modulation of autophagy | Q35138227 | ||
| Gut microbiota and probiotics in colon tumorigenesis | Q35141302 | ||
| Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer. | Q35601294 | ||
| A Selected Lactobacillus rhamnosus Strain Promotes EGFR-Independent Akt Activation in an Enterotoxigenic Escherichia coli K88-Infected IPEC-J2 Cell Model | Q35615534 | ||
| Lack of Vitamin D Receptor Causes Dysbiosis and Changes the Functions of the Murine Intestinal Microbiome | Q35653608 | ||
| Immunobiotic Lactobacillus jensenii elicits anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the Toll-like receptor signaling pathway | Q35665421 | ||
| Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract | Q35679288 | ||
| Vitamin D receptor pathway is required for probiotic protection in colitis | Q35687364 | ||
| Probiotic BIFICO cocktail ameliorates Helicobacter pylori induced gastritis | Q35692273 | ||
| Low folate levels may protect against colorectal cancer | Q35760847 | ||
| Lactobacillus rhamnosus CNCMI-4317 Modulates Fiaf/Angptl4 in Intestinal Epithelial Cells and Circulating Level in Mice. | Q35800407 | ||
| Probiotic (Enterococcus faecium) induced responses of the hepatic proteome improves metabolic efficiency of broiler chickens (Gallus gallus) | Q35910092 | ||
| Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review | Q36237066 | ||
| A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas | Q36274959 | ||
| Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trial | Q36405806 | ||
| Lactobacillus rhamnosus GR-1 Ameliorates Escherichia coli-Induced Inflammation and Cell Damage via Attenuation of ASC-Independent NLRP3 Inflammasome Activation | Q36575117 | ||
| Probiotics and the incidence of colorectal cancer: when evidence is not evident. | Q36720519 | ||
| The Vitamin D Receptor, Inflammatory Bowel Diseases, and Colon Cancer | Q36955934 | ||
| Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence. | Q36960938 | ||
| Vitamin D and human health: lessons from vitamin D receptor null mice. | Q36973933 | ||
| Genetic features of circular bacteriocins produced by Gram-positive bacteria. | Q37012200 | ||
| Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis | Q37167679 | ||
| Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases | Q37214848 | ||
| Integration of metabolism and inflammation by lipid-activated nuclear receptors | Q37225357 | ||
| Combination with methotrexate and cyclophosphamide attenuated maturation of dendritic cells: inducing Treg skewing and Th17 suppression in vivo | Q37249844 | ||
| Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression | Q37521881 | ||
| Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease | Q37579365 | ||
| Colonic vitamin D metabolism: implications for the pathogenesis of inflammatory bowel disease and colorectal cancer | Q37908311 | ||
| Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism | Q38343341 | ||
| Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. | Q38437716 | ||
| Associations of Probiotics with Vitamin D and Leptin Receptors and their Effects on Colon Cancer | Q38489907 | ||
| Lactobacillus reuteri Inhibition of Enteropathogenic Escherichia coli Adherence to Human Intestinal Epithelium | Q38684853 | ||
| Protective effects of Lactobacillus plantarum on epithelial barrier disruption caused by enterotoxigenic Escherichia coli in intestinal porcine epithelial cells | Q38782142 | ||
| Lactobacillus delbrueckii TUA4408L and its extracellular polysaccharides attenuate enterotoxigenic Escherichia coli-induced inflammatory response in porcine intestinal epitheliocytes via Toll-like receptor-2 and 4. | Q38978054 | ||
| Mechanisms Underlying the Anti-Inflammatory Effects of Clinacanthus nutans Lindau Extracts: Inhibition of Cytokine Production and Toll-Like Receptor-4 Activation | Q39176750 | ||
| Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. | Q39305621 | ||
| Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model | Q39322394 | ||
| Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. | Q39364772 | ||
| A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome | Q39396709 | ||
| Lactobacillus fermentum Suo Attenuates HCl/Ethanol Induced Gastric Injury in Mice through Its Antioxidant Effects | Q39540509 | ||
| Impact of a probiotic Enterococcus faecalis in a gnotobiotic mouse model of experimental colitis | Q39604749 | ||
| Lactobacillus rhamnosus GR-1 Limits Escherichia coli-Induced Inflammatory Responses via Attenuating MyD88-Dependent and MyD88-Independent Pathway Activation in Bovine Endometrial Epithelial Cells | Q39728589 | ||
| Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function | Q39940770 | ||
| Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair | Q40211588 | ||
| Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells | Q40333778 | ||
| Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells | Q40403481 | ||
| Preventive and therapeutic effects of Lactobacillus paracasei B21060-based synbiotic treatment on gut inflammation and barrier integrity in colitic mice | Q40995492 | ||
| Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease | Q41886049 | ||
| Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. | Q42218324 | ||
| Enhancement of gastric mucosal integrity by Lactobacillus rhamnosus GG. | Q42512570 | ||
| Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats | Q42518174 | ||
| Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier | Q43132701 | ||
| Vitamin D, the gut microbiome, and the hygiene hypothesis. How does asthma begin? | Q43216276 | ||
| Probiotics: a proactive approach to health. A symposium report | Q43594513 | ||
| Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial | Q43739868 | ||
| Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial. | Q44066560 | ||
| Vitamin d deficiency is associated with ulcerative colitis disease activity | Q44522400 | ||
| Calcium and vitamin D intake and risk of colorectal cancer: the Multiethnic Cohort Study | Q45225692 | ||
| Protective effects of probiotic Lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. | Q45927748 | ||
| Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease | Q46495260 | ||
| Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission | Q46515415 | ||
| Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats | Q46650965 | ||
| Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier | Q46930482 | ||
| P433 | issue | 9 | |
| P921 | main subject | vitamin D | Q175621 |
| probiotics | Q1816730 | ||
| P304 | page(s) | 876-887 | |
| P577 | publication date | 2016-12-02 | |
| P1433 | published in | Current Medicinal Chemistry | Q3007710 |
| P1476 | title | Vitamin D/VDR, Probiotics, and Gastrointestinal Diseases | |
| P478 | volume | 24 |
| Q64117691 | Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients |
| Q58702835 | Dietary vitamin D, vitamin D receptor, and microbiome |
| Q51737061 | Health Risks of Hypovitaminosis D: A Review of New Molecular Insights. |
| Q64102240 | Interactions Between the Gut Microbiota and the Host Innate Immune Response Against Pathogens |
| Q53687965 | Probiotic Supplementation in Morbid Obese Patients Undergoing One Anastomosis Gastric Bypass-Mini Gastric Bypass (OAGB-MGB) Surgery: a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. |
| Q92059370 | Provitamin D3 modulation through prebiotics supplementation: simulation based assessment |
| Q64263827 | Vitamin D Deficiency in the Gulf Cooperation Council: Exploring the Triad of Genetic Predisposition, the Gut Microbiome and the Immune System |
| Q49311496 | Vitamin D and gastrointestinal cancer |
| Q61446021 | Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome |
| Q94474147 | Vitamin D receptor promotes healthy microbial metabolites and microbiome |
| Q90394256 | tRNA Queuosine Modification Enzyme Modulates the Growth and Microbiome Recruitment to Breast Tumors |
Search more.